Pharmaceutical compositions containing prostacyclin synthase gene
CA 2411056 C · Owner: Hatae, Toshihisa · Inventors: Hatae, Toshihisa; Tanabe, Tadashi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to: pharmaceutical compositions for inducing apoptosis in cells, the pharmaceutical compositions comprising a prostacyclin synthase gene as an active ingredient; pharmaceutical compositions for gene therapy of cancer the , pharmaceutical compositions comprising the above pharmaceutical compositions for inducing apoptosis as an active ingredient; and a screening method for an agent that induces apoptosis in a cell the , method comprising determining the activation of peroxisome proliferator-activated recptor (PPAR)-.delta. in the presence of a test substance. The pharmaceutical composition of the present invention for inducing apoptosis enables treatment …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 21, 2000 and granted May 10, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended November 21, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 21, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.